Waddell & Reed Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $136M | Buy |
1,622,034
+3,624
| +0.2% | +$306K | 0.28% | 101 |
|
|
2020
Q4 | $148M | Sell |
1,618,410
-80,333
| -5% | -$6.66M | 0.31% | 88 |
|
|
2020
Q3 | $136M | Sell |
1,698,743
-34,785
| -2% | -$2.71M | 0.33% | 79 |
|
|
2020
Q2 | $120M | Sell |
1,733,528
-24,733
| -1% | -$1.76M | 0.31% | 87 |
|
|
2020
Q1 | $111M | Sell |
1,758,261
-36,981
| -2% | -$2.67M | 0.36% | 76 |
|
|
2019
Q4 | $140M | Sell |
1,795,242
-274,794
| -13% | -$21.5M | 0.35% | 74 |
|
|
2019
Q3 | $152M | Sell |
2,070,036
-66,504
| -3% | -$4.67M | 0.39% | 66 |
|
|
2019
Q2 | $132M | Sell |
2,136,540
-70,182
| -3% | -$4.24M | 0.33% | 86 |
|
|
2019
Q1 | $141M | Sell |
2,206,722
-202,428
| -8% | -$11.6M | 0.35% | 70 |
|
|
2018
Q4 | $123M | Sell |
2,409,150
-297,480
| -11% | -$15.1M | 0.35% | 72 |
|
|
2018
Q3 | $157M | Sell |
2,706,630
-224,850
| -8% | -$11M | 0.35% | 76 |
|
|
2018
Q2 | $142M | Sell |
2,931,480
-215,391
| -7% | -$10.1M | 0.33% | 87 |
|
|
2018
Q1 | $146M | Sell |
3,146,871
-411,783
| -12% | -$17.9M | 0.33% | 78 |
|
|
2017
Q4 | $134M | Sell |
3,558,654
-2,886,648
| -45% | -$106M | 0.3% | 91 |
|
|
2017
Q3 | $235M | Sell |
6,445,302
-74,109
| -1% | -$2.83M | 0.52% | 51 |
|
|
2017
Q2 | $257M | Sell |
6,519,411
-234,861
| -3% | -$8.57M | 0.57% | 47 |
|
|
2017
Q1 | $212M | Sell |
6,754,272
-388,074
| -5% | -$12.1M | 0.45% | 64 |
|
|
2016
Q4 | $223M | Buy |
7,142,346
+378,972
| +6% | +$12.3M | 0.49% | 56 |
|
|
2016
Q3 | $272M | Buy |
6,763,374
+3,291,240
| +95% | +$124M | 0.56% | 47 |
|
|
2016
Q2 | $115M | Buy |
3,472,134
+463,872
| +15% | +$15.9M | 0.24% | 108 |
|
|
2016
Q1 | $88.5M | Buy |
3,008,262
+2,643,930
| +726% | +$73M | 0.17% | 155 |
|
|
2015
Q4 | $9.59M | Buy |
+364,332
| New | +$9.46M | 0.02% | 418 |
|